Literature DB >> 17574251

Significance of levels of IL-6 and IL-8 after trauma: a study of 11 cytokines post-mortem using multiplex immunoassay.

S Mimasaka1, M Funayama, M Hashiyada, M Nata, S Tsunenari.   

Abstract

PURPOSE: To identify cytokines useful for diagnosis of traumatic death.
METHODS: Post-mortem serum levels of 11 cytokines were assayed for 43 people who died of traumatic injury or from non-traumatic causes. Levels of granulocyte-macrophage colony stimulating factor, gamma interferon, interleukin IL-1beta, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-13, and tumour necrosis factor-alpha were measured using multiplex immunoassay.
RESULTS: Levels of granulocyte-macrophage colony stimulating factor (p<0.01), IL-6 (p<0.001), and IL-8 (p<0.01) among the traumatic group were significantly higher than those among the non-traumatic group. Anatomical trauma severity was also estimated using the total abbreviated injury scale and injury severity score, revealing significant positive correlations between the former and IL-6 (rs=0.6523, p<0.01) and IL-8 levels (rs=0.6584, p<0.01).
CONCLUSIONS: Levels of IL-6 and IL-8 assist differentiation between traumatic and non-traumatic death, are useful objective indices of trauma severity and can support a diagnosis of traumatic death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574251     DOI: 10.1016/j.injury.2007.02.045

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  20 in total

Review 1.  Postmortem chemistry update part II.

Authors:  Cristian Palmiere; Patrice Mangin
Journal:  Int J Legal Med       Date:  2011-10-09       Impact factor: 2.686

2.  Blood manufacturing methods affect red blood cell product characteristics and immunomodulatory activity.

Authors:  Ruqayyah J Almizraq; Philip J Norris; Heather Inglis; Somaang Menocha; Mathijs R Wirtz; Nicole Juffermans; Suchitra Pandey; Philip C Spinella; Jason P Acker; Jennifer A Muszynski
Journal:  Blood Adv       Date:  2018-09-25

Review 3.  Transfusion-associated microchimerism: the hybrid within.

Authors:  Evan M Bloch; Rachael P Jackman; Tzong-Hae Lee; Michael P Busch
Journal:  Transfus Med Rev       Date:  2012-10-24

Review 4.  Immune depression in musculoskeletal trauma.

Authors:  Olav Reikerås
Journal:  Inflamm Res       Date:  2010-02-11       Impact factor: 4.575

5.  Distinct roles of trauma and transfusion in induction of immune modulation after injury.

Authors:  Rachael P Jackman; Garth H Utter; Marcus O Muench; John W Heitman; Matthew M Munz; Robert W Jackman; Hope H Biswas; Ryan M Rivers; Leslie H Tobler; Michael P Busch; Philip J Norris
Journal:  Transfusion       Date:  2012-03-27       Impact factor: 3.157

6.  Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients.

Authors:  Adrian Billeter; Matthias Turina; Burkhardt Seifert; Ladislav Mica; Reto Stocker; Marius Keel
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

7.  Role of interleukin-6 as an early marker of fat embolism syndrome: a clinical study.

Authors:  Shiva Prakash; Ramesh Kumar Sen; Sujit Kumar Tripathy; Indu Mohini Sen; R R Sharma; Sadhna Sharma
Journal:  Clin Orthop Relat Res       Date:  2013-02-20       Impact factor: 4.176

8.  Neutrophil-to-lymphocyte ratio (NLR) distribution shows a better kinetic pattern than C-reactive protein distribution for the follow-up of early inflammation after total knee arthroplasty.

Authors:  J C Yombi; P E Schwab; E Thienpont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-24       Impact factor: 4.342

Review 9.  Immunomodulation in transfused trauma patients.

Authors:  Rachael P Jackman
Journal:  Curr Opin Anaesthesiol       Date:  2013-04       Impact factor: 2.706

10.  Post-mortem in situ stability of serum markers of cerebral damage and acute phase response.

Authors:  Benjamin Ondruschka; Lina Woydt; Michael Bernhard; Heike Franke; Holger Kirsten; Sabine Löffler; Dirk Pohlers; Niels Hammer; Jan Dreßler
Journal:  Int J Legal Med       Date:  2018-08-30       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.